Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, Sl00ß

  • K. Kojima
  • H. Wekerle
  • H. Lassmann
  • T. Berger
  • Ch. Linington


S100β protein is a calcium binding protein that is not only expressed by astrocytes in the CNS, but also in many other tissues including the eye, thymus, spleen and lymph nodes. Despite this tissue distribution, which was expected to induce a firm state of self-tolerance to Sl00β, the Lewis rat mounts a strong T cell response to this autoantigen. The pathogenicity of this T cell response was demonstrated by the adoptive transfer of Sl00β-specific T cells which induced an inflammatory response in the CNS and eye of naive syngeneic recipients. The distribution of lesions in this novel model of EAE resembles that seen in some patients with MS, suggesting that the initial autoimmune insult in MS may be directed against a non-myelin antigen co-expressed in the CNS and extra-neural tissues.


Experimental Autoimmune Encephalomyelitis Myelin Basic Protein Optic Neuritis Adoptive Transfer Experimental Allergic Encephalomyelitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tausch GS, Waldor MK, Zamvil SS, McDevitt HO, Steinman L (1988) Limited heterogeneity of T cell receptors from T lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54: 263–273PubMedCrossRefGoogle Scholar
  2. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE (1989) Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Thl lymphokine subtype. Cell Immunol 124: 132–143PubMedCrossRefGoogle Scholar
  3. Arnold B, Schönrich G, Hämmerling GJ (1993) Multiple levels of peripheral tolerance. Immunol Today 14: 12–14PubMedCrossRefGoogle Scholar
  4. Barbatelli G, Morroni M, Vinesi P, Cinti S, Michetti F (1993) S-100 protein in rat adipose tissue under different functional conditions: a morphological, immunocytochemical and immunochemical study. Exp Cell Res 208: 226–231PubMedCrossRefGoogle Scholar
  5. Baron JL, Madri JA, Ruddle NH, Hashim GA, Janeway CA (1993) Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177: 57–68PubMedCrossRefGoogle Scholar
  6. Ben-Nun A, Wekerle H, Cohen IR (1981) Vaccination against autoimmune encephalomyelitis using attenuated cells of a T lymphocyte line reactive against myelin basic protein. Nature 292: 60–61PubMedCrossRefGoogle Scholar
  7. Berger BC, Leopold IH (1968) The incidence of uveitis in multiple sclerosis. Am J Opthalmol 62: 540Google Scholar
  8. Brosnan CF, Bornstein MB, Bloom BR (1981) The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 126: 614–620PubMedGoogle Scholar
  9. Burns FR, Li X, Shen H, Offner H, Chou YK, Vandenbark AA, Heber-Katz E (1989) Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Va and Vß chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 169: 27–40PubMedCrossRefGoogle Scholar
  10. Chluba J, Steeg C, Becker A, Wekerle H, Epplen JT (1989) T cell receptor ß chain usage in myelin basic protein-specific rat T lymphocytes. Eur J Immunol 19: 279–284PubMedCrossRefGoogle Scholar
  11. Cocchia D (1981) Immunocytochemical localization of S-100 protein in the brain of adult rat. Cell Tissue Res 214: 529-534PubMedCrossRefGoogle Scholar
  12. Cocchia D, Tiberio G, Santarelli R, Michetti F (1983) S-100 protein in “follicular dendritic” cells of rat lymphoid organs. An immunohistochemical and immunocytochemical study. Cell Tissue Res 230: 95–103PubMedCrossRefGoogle Scholar
  13. Higley HR, Rowden G (1984) Thymic interdigitating reticulum cells demonstrated by immunocytochemistry. Thymus 6: 243–253PubMedGoogle Scholar
  14. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246: 668-671PubMedCrossRefGoogle Scholar
  15. Huitinga I, Van Rooijen N, De Groot CJA, Uitdehaag BMJ, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172: 1025–1033PubMedCrossRefGoogle Scholar
  16. Koh DR, Fung-Leung WP, Ho A, Gray D, Acha-Orbea H, Mak TW (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256: 1210–1213PubMedCrossRefGoogle Scholar
  17. Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C (1994) Experimental autoimmune panencephalo-myelitis and uveoretinitis transferred to the Lewis rat by T cells specific for the S100ß molecule, a calcium binding protein of astroglia. J Exp Med 180Google Scholar
  18. Kondo H, Takahashi H, Takahashi Y (1984) Immunohistochemical study of S-100 protein in the postnatal development of Müller cells and astrocytes in the rat retina. Cell Tissue Res 238: 503–508PubMedCrossRefGoogle Scholar
  19. Kuwano R, Usui H, Maeda T, Araki K, Yamakuni T, Kurihara T, Takahashi Y (1987) Tissue distribution of rat S-100α and ß subunit mRNAs. Mol Brain Res 2: 79–82CrossRefGoogle Scholar
  20. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75: 566–576PubMedCrossRefGoogle Scholar
  21. Lider O, Reshef T, Béraud E, Ben-Nun A, Cohen IR (1988) Anti-idiotypic network induced by T-cell vaccination against experimental autoimmune encephalomyelitis. Science 239: 181–183PubMedCrossRefGoogle Scholar
  22. Lightman S, McDonald WI, Bird AC, Francis DA, Hoskins A, Batchelor JR, Halliday AM (1987) Retinal nervous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 110: 405–414PubMedCrossRefGoogle Scholar
  23. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu H, Lassmann H, Wekerle H (1993) T cells specific for the myelin-oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23: 1364–1372PubMedCrossRefGoogle Scholar
  24. Lucarelli MJ, Pepose JS, Arnold AC, Foos RY (1991) Immunopathological features of retinal lesions in multiple sclerosis. Ophthalmology 98: 1652–1656PubMedGoogle Scholar
  25. Martin R, McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10: 153-187PubMedCrossRefGoogle Scholar
  26. Mustafa M, Vingsbo C, Olsson T, Höjeberg B, Holmdahl R (1993) The major histocompatibility complex influences myelin basic protein 63–88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis. Eur J Immunol 23: 3089–3095PubMedCrossRefGoogle Scholar
  27. Naparstek Y, Cohen IR, Fuks Z, Vlodavsky I (1984) Activated T lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature 310: 241–244PubMedCrossRefGoogle Scholar
  28. Omlin FX, Webster H de F, Palkovits CG, Cohen SR (1982) Immunocytochemical localization of basic protein (MBP) in the major dense line regions of central and peripheral myelin. J Cell Biol 95: 242–248PubMedCrossRefGoogle Scholar
  29. Shashoua VE, Hesse GW, Moore BW (1984) Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J Neurochem 42: 1536–1541PubMedCrossRefGoogle Scholar
  30. Shaw PJ, Smith NM, Inca PG, Bates D (1987) Chronic periphlebitis retinae in multiple sclerosis. A histological study. J Neurol Sci 77: 147–154PubMedCrossRefGoogle Scholar
  31. Simmons RD, Cattle BA (1993) Sialyl ligands facilitate lymphocyte accumulation during inflammation of the central nervous system. J Neuroimmunol 41: 123–130CrossRefGoogle Scholar
  32. Simmons RD, Cattle BA, Hugh AR, Willenborg DO (1992) Lymphocytes utilize sialylat-ed surface molecules to accumulate in developing lesions of autoimmune encephalomyelitis. Autoimmun 14: 17–21CrossRefGoogle Scholar
  33. Spreca A, Rambotti MG, Rende M, Saccardi C, Aisa MC, Giambanca I, Donato R (1989) Immunocytochemical localization of S-100ß protein in degenerating and regenerating rat sciatic nerves. J Histochem Cytochem 37: 441–446PubMedCrossRefGoogle Scholar
  34. Stefansson K, Wollmann RL, Moore BW (1982) Distribution of S-100 protein outside the central nervous system. Brain Res 234: 309–317PubMedCrossRefGoogle Scholar
  35. Sun D, Wekerle H (1986) Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 320: 70–72PubMedCrossRefGoogle Scholar
  36. Sun D, Ben-Nun A, Wekerle H (1988) Regulatory circuits in autoimmunity: recruitment of counterregulatory CD8+ T cells by encephalitogenic CD4+ T line cells. Eur J Immunol 18: 1993–2000PubMedCrossRefGoogle Scholar
  37. Takahashi K, Yoshida T, Hayashi K, Sonobe H, Ohtsuki Y (1987) S-100 beta positive human T lymphocytes: their characteristics and behavior under normal and pathologic conditions. Blood 70: 214–220PubMedGoogle Scholar
  38. Tsukada N, Koh C-S, Yanagisawa N, Okano A, Taketomi T (1989) Autoimmune encephalomyelitis in rhesus monkeys induced by immunization with cerebral endothelial cell membranes. Acta Neuropathol 77: 39–46CrossRefGoogle Scholar
  39. Urban JL, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L (1988) Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54: 577–592PubMedCrossRefGoogle Scholar
  40. Ushiki T, Iwanaga T, Masuda T, Takahashi Y, FujitaT (1984) Distribution and ultrastructure of S-100-immunoreactive cells in the human thymus. Cell Tissue Res 235: 509–514PubMedCrossRefGoogle Scholar
  41. Van Eldik LJ, Zimmer DB (1987) Secretion of S-100 from rat C6 glioma cells. Brain Res 436: 367–370PubMedCrossRefGoogle Scholar
  42. Vandenbark AA, Hashim G, Offner H (1989) Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341: 541–544PubMedCrossRefGoogle Scholar
  43. Yamamura T, Namikawa T, Endoh M, Kunishita T, Tabira T (1986) Passive transfer of experimental allergic encephalomyelitis induced by proteolipid apoprotein. J Neurol Sci 76: 269–275PubMedCrossRefGoogle Scholar
  44. Zaller DM, Osman G, Kanagawa O, Hood L (1990) Preventio and treatment of murine experimental allergic encephalomyelitis with T cell receptor Vß-specific antibodies. J Exp Med 171: 1943–1956PubMedCrossRefGoogle Scholar
  45. Zimmer DB, Van Eldik LJ (1987) Tissue distribution of rat S-100α and S-100ß and S-100 binding proteins. Am J Physiol 252: 285–289Google Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • K. Kojima
    • 1
  • H. Wekerle
    • 1
  • H. Lassmann
    • 2
  • T. Berger
    • 2
  • Ch. Linington
    • 1
  1. 1.Department of NeuroimmunlogyMax-Planck Institute for PsychiatryMartinsriedFederal Republic of Germany
  2. 2.Neurological InstituteUniversity of ViennaAustria

Personalised recommendations